Reuters logo
BRIEF-Titan Pharmaceuticals Partners With Molteni To Market Probuphine In Europe
November 28, 2017 / 12:14 PM / 14 days ago

BRIEF-Titan Pharmaceuticals Partners With Molteni To Market Probuphine In Europe

Nov 28 (Reuters) - Titan Pharmaceuticals Inc:

* TITAN PHARMACEUTICALS PARTNERS WITH MOLTENI TO MARKET PROBUPHINE® IN EUROPE

* TITAN PHARMACEUTICALS - ‍ENTERED BINDING TERM SHEET UNDER WHICH CO WILL GRANT MOLTENI EXCLUSIVE LICENSE TO COMMERCIALIZE PROBUPHINE IN EUROPEAN UNION​

* TITAN PHARMACEUTICALS INC - ‍TITAN AND MOLTENI EXPECT TO ENTER INTO DEFINITIVE LICENSE AND DISTRIBUTION AGREEMENT DURING Q1 OF 2018​

* TITAN PHARMACEUTICALS - TERM SHEET PROVIDES MOLTENI TO PAY CO UPFRONT, NON-REFUNDABLE LICENSE FEE OF EUR 2.0 MILLION UPON EXECUTION OF LICENSE DEAL​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below